| scholarly article | Q13442814 |
| P50 | author | Thomas E. Carey | Q52350909 |
| Douglas B Chepeha | Q57078605 | ||
| Avraham Eisbruch | Q64584930 | ||
| Carol R Bradford | Q90017570 | ||
| Gregory Wolf | Q96101640 | ||
| Susan G Urba | Q114735947 | ||
| Theodoros N Teknos | Q124366306 | ||
| Bhavna Kumar | Q124366307 | ||
| Kitrina G Cordell | Q124366308 | ||
| Francis P Worden | Q124366310 | ||
| Mark E Prince | Q124366319 | ||
| Julia S Lee | Q124366327 | ||
| David M Kurnit | Q124366328 | ||
| P2093 | author name string | Felix Y Feng | |
| Jeffrey S Moyer | |||
| Heather M Walline | |||
| Jonathan B McHugh | |||
| Jessica H Maxwell | |||
| Jay Stoerker | |||
| Preston D Ward | |||
| Samantha J Davis | |||
| P2860 | cites work | Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review | Q22306450 |
| Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. | Q31992287 | ||
| Evidence for a causal association between human papillomavirus and a subset of head and neck cancers | Q33180284 | ||
| Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies | Q33836183 | ||
| Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? | Q34667925 | ||
| Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States | Q34743604 | ||
| Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial | Q34749494 | ||
| Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers | Q34760882 | ||
| Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. | Q34812060 | ||
| Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract | Q35154934 | ||
| Clinical implications of human papillomavirus in head and neck cancers | Q36416436 | ||
| The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus | Q36717732 | ||
| Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis | Q36839249 | ||
| Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number | Q37342399 | ||
| EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer | Q37348956 | ||
| Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer | Q43428716 | ||
| Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma | Q43732858 | ||
| Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems | Q44263733 | ||
| Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil | Q44503076 | ||
| Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years | Q46214415 | ||
| Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. | Q46686980 | ||
| Estimates of the worldwide incidence of 25 major cancers in 1990. | Q50638996 | ||
| HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. | Q53579250 | ||
| High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma | Q56532872 | ||
| Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas | Q72333641 | ||
| Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri | Q73721770 | ||
| Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy | Q74820523 | ||
| Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911 | Q81464422 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oropharynx cancer | Q2031424 |
| P304 | page(s) | 1226-1235 | |
| P577 | publication date | 2010-02-09 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence | |
| P478 | volume | 16 |
| Q92345986 | A Hidden Epidemic of "Intermediate Risk" Oropharynx Cancer |
| Q36630457 | A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide |
| Q38850017 | ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas |
| Q41758408 | Accuracy of computed tomography to predict extracapsular spread in p16-positive squamous cell carcinoma |
| Q53090717 | Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma. |
| Q99597187 | Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study |
| Q43843212 | Cancers of the upper aerodigestive tract associated with human papillomavirus |
| Q35870672 | Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study |
| Q96648909 | Characteristics of Head and Neck Squamous Cell Carcinoma Cell Lines Reflect Human Tumor Biology Independent of Primary Etiologies and HPV Status |
| Q45126102 | Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis |
| Q40644475 | Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population |
| Q30373904 | Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. |
| Q38169227 | Classifying squamous cell carcinoma of the head and neck: prognosis, prediction and implications for therapy |
| Q31127773 | Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study |
| Q64243615 | Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana |
| Q49948804 | Combined surgery and radiation improves survival of tonsil squamous cell cancers. |
| Q58792602 | Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure |
| Q28485279 | Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics |
| Q59352690 | Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma |
| Q41819835 | Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer |
| Q36590501 | Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer |
| Q35533875 | Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry |
| Q42333316 | Dual role for p16 in the metastasis process of HPV positive head and neck cancers. |
| Q42232427 | Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma |
| Q38070999 | Emerging insights into head and neck cancer metastasis |
| Q89594956 | Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery |
| Q26827810 | Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. |
| Q37299951 | Evidence that alpha-9 human papillomavirus infections are a major etiologic factor for oropharyngeal carcinoma in black South Africans |
| Q42288427 | Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. |
| Q50026288 | Facial flushing after alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper gastrointestinal tract. |
| Q38218898 | Factors contributing to recurrence of oral cavity and laryngeal tumors and estimation of tumor age. |
| Q37164556 | Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine |
| Q35124426 | Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis |
| Q40611651 | Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma |
| Q34547468 | Geriatric oncology: comparing health related quality of life in head and neck cancer patients |
| Q36848497 | HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience |
| Q89170715 | HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population |
| Q26853669 | HPV in oropharyngeal cancer: the basics to know in clinical practice |
| Q35762184 | HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management |
| Q58197295 | Head and neck cancer: from research to therapy and cure |
| Q37050088 | High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma. |
| Q33726331 | High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. |
| Q28386178 | Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis |
| Q58766357 | How Does Smoking Change the Clinicopathological Characteristics of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma? One Medical Center Experience |
| Q36165303 | Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population |
| Q42202881 | Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck: A Growing Epidemic |
| Q38583292 | Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials |
| Q34698871 | Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population |
| Q42215642 | Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy |
| Q37789092 | Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy |
| Q37000170 | Human papilloma virus prevalence in a multiethnic screening population |
| Q33901342 | Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients |
| Q38023262 | Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know |
| Q39202422 | Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases |
| Q34764776 | Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinoma |
| Q34344038 | Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy |
| Q58828827 | Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma |
| Q35161119 | Human papillomavirus, smoking, and head and neck cancer |
| Q34342397 | Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival |
| Q34129454 | Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor |
| Q41733564 | Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma |
| Q91674233 | Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma |
| Q91457914 | Impact of active smoking on outcomes in HPV+ oropharyngeal cancer |
| Q48154001 | Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery |
| Q39448913 | Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation |
| Q35669647 | Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy |
| Q35602143 | Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study |
| Q40319208 | Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. |
| Q27024764 | Is radiation dose reduction the right answer for HPV-positive head and neck cancer? |
| Q37209937 | Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma |
| Q36282202 | Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. |
| Q30252081 | Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? |
| Q33936862 | Management of oropharyngeal cancer: a cross-sectional review of institutional practice at a large Canadian referral centre |
| Q36218314 | Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer |
| Q37788246 | Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications |
| Q35827866 | NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas. |
| Q37943790 | Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? |
| Q36226602 | No Ifs, No Butts: Compliance with Smoking Cessation in Secondary Care Guidance (NICE PH48) by Providers of Cancer Therapies (Radiotherapy and Chemotherapy) in the UK. |
| Q37707877 | Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. |
| Q37593461 | Nuances in the changing epidemiology of head and neck cancer |
| Q35673572 | Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment |
| Q26799210 | Oral cavity and oropharyngeal squamous cell carcinoma--an update |
| Q34147649 | Oral epithelial stem cells - implications in normal development and cancer metastasis |
| Q47162244 | Orbital mass as first presentation of metastatic p16-positive oropharyngeal squamous cell carcinoma |
| Q35990622 | Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer |
| Q91600822 | Positivity Rates in Oropharyngeal and Nonoropharyngeal Head and Neck Cancer in the VA |
| Q91792666 | Post-diagnosis smoking and risk of cardiovascular, cancer, and all-cause mortality in survivors of 10 adult cancers: a prospective cohort study |
| Q38966104 | Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer |
| Q36187842 | Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas. |
| Q33986942 | Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer |
| Q58127069 | Prognosis of HPV-positive head and neck cancers: implication of smoking and immunosuppression |
| Q34394972 | Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer |
| Q54288891 | Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. |
| Q35214908 | Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma |
| Q35071687 | Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality. |
| Q45346918 | Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity |
| Q37129819 | Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma |
| Q37709252 | Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck |
| Q41592768 | Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades |
| Q38445391 | Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy |
| Q34667840 | Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer |
| Q36109779 | Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer |
| Q35917835 | Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck |
| Q90537899 | Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma |
| Q47844913 | Smoking at diagnosis and survival in cancer patients |
| Q38877866 | Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation |
| Q40224459 | Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma. |
| Q41659557 | Stability of methylation markers in head and neck squamous cell carcinoma. |
| Q35861606 | Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history |
| Q40793270 | Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures |
| Q42232492 | Surgically treated oropharyngeal cancer: risk factors and tumor characteristics. |
| Q50870633 | Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. |
| Q90734085 | Systematic review on location and timing of distant progression in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas |
| Q26745535 | Systematizing support in cessation smoking to improve care for cancer patients |
| Q92691192 | The changing therapeutic landscape of head and neck cancer |
| Q37925133 | The emerging era of personalized therapy in squamous cell carcinoma of the head and neck |
| Q28388257 | The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis |
| Q90304229 | The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status |
| Q35838231 | The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies |
| Q40081693 | The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma |
| Q36097436 | Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer |
| Q53264115 | Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. |
| Q36013039 | UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line |
| Q37170012 | Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome |
| Q37726485 | Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. |
| Q27026269 | What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer? |
Search more.